Biopharma | May 18, 2026
Kotak Alts invests Rs. 200 million in Cellogen Therapeutics
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
The move signals a strategic pivot toward deeper integration between clinical leadership and medical technology developers
The state has received Rs. 84,000 crore investments in the sector over two years, positioning Hyderabad among the world’s leading life sciences clusters
The company’s shares of confidence were underlined by an upgraded 2026 outlook, with Merck now expecting annual net sales of up to €21.4 billion and EBITDA pre of as much as €6.1 billion
Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care
High-resolution analytical platforms from Agilent Technologies will be made available through C-CAMP’s shared infrastructure model under expanded collaboration
The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments
The medical-grade Angelas diode laser calibrated at a 1470 nm wavelength supports microsurgeries across multiple specialties
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
Subscribe To Our Newsletter & Stay Updated
